Risk Warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please click here to read our full Risk Warning.

78% of retail investor accounts lose money when trading CFDs with this provider.

Aurora Cannabis Inc.

Aurora Cannabis (ticker – ACB) is a Canadian medical cannabis producer. It is headquartered in Vancouver, Canada.

Aurora Cannabis is one of a select number of licensed companies which are GMP-certified for cultivation, import, release and distribution. That gives it a considerable competitive advantage in a market with over 400 million potential customers and very few companies which are currently able to meet this demand.

Aurora Cannabis's shares are traded on the US and Canadian stock markets.

Revenue – Aurora Cannabis
According to its 2017 financial results, the company's income stood at USD 18.1 million. It is projecting a 205.4% increase (to a total of USD 55.2 million) for financial 2019.

Brand goodwill
With the growing number of countries passing medical cannabis legislation, the company has adopted an aggressive international expansion strategy. It is currently looking at expanding into Germany, Denmark, Italy and Australia.

Shares and quoted stock prices – Aurora Cannabis
The company's shares are traded on the New York and Toronto stock exchanges. With a unit share price of USD 6.25, the company's market capitalization stands at USD 6.23 billion.

Earnings potential
In the four years immediately following its IPO in 2014, the company's share price has risen by 586.8%. That equates to an average of 146.7% per year, which beats any savings account yield hands down.

Get this report